# A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function

> **NCT07625618** · PHASE1 · COMPLETED · sponsor: **Wuhan Createrna Science and Technology Co., Ltd** · enrollment: 24 (actual)

## Conditions studied

- Hepatic Insufficiency (MeSH ID: D048550)

## Interventions

- **DRUG:** MY008211A tablets

## Key facts

- **NCT ID:** NCT07625618
- **Lead sponsor:** Wuhan Createrna Science and Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-20
- **Primary completion:** 2024-12-28
- **Final completion:** 2024-12-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07625618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07625618, "A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07625618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*